Brief: Cardiff Oncology Inc - QTRLY Loss Per Share $0.24
04/08/2022 22:38
Cardiff Oncology Inc CRDF.O :
* CARDIFF ONCOLOGY REPORTS SECOND QUARTER 2022 RESULTS AND
PROVIDES BUSINESS UPDATES
* QTRLY LOSS PER SHARE $0.24
* Q2 EARNINGS PER SHARE VIEW $-0.25 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn2VPnsha
Further company coverage: CRDF.O
Recent news on Cardiff Oncology
See all newsBrief: Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia
Corrected: Cardiff Oncology Q2 operating expenses fall on lower R&D costs
Cardiff Oncology Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Cardiff Oncology sinks on direct equity offering